Publications

Rosser, A. & Bachoud-Levi, A. (2012). Clinical trials of neural transplantation in Huntington's disease. Progress in brain research, 200, 345-71. doi:10.1016/B978-0-444-59575-1.00016-8

Thiriez, C., Itti, E., Fenelon, G., Evangelista, E., Meignan, M., Cesaro, P. & Remy, P. (2015). Clinical routine use of dopamine transporter imaging in 516 consecutive patients. Journal of neurology, 262(4), 909-15. doi:10.1007/s00415-014-7634-y

Lefaucheur, J., Bachoud-Levi, A., Bourdet, C., Grandmougin , T., Hantraye, P., Cesaro, P., Degos, J., Peschanski, M. & Lisovoski , F. (2002). Clinical relevance of electrophysiological tests in the assessment of patients with Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 17(6), 1294-301. doi:10.1002/mds.10273

Cubo, E., Ramos-Arroyo, M., Martinez-Horta, S., Martínez-Descalls, A., Calvo, S., Gil-Polo, C. & European Hd, N. (2016). Clinical manifestations of intermediate allele carriers in Huntington disease. Neurology, 87(6), 571-8. doi:10.1212/WNL.0000000000002944

Shin, M., Jan, C., Jacquard, C., Jarraya, B., Callebert, J., Launay, J., Hantraye, P., Remy, P., Palfi, S. & Brouillet, E. (2011). Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration. Neurobiology of aging, 32(11), 2100-2. doi:10.1016/j.neurobiolaging.2009.11.015

Bachoud-Levi, A., Massart, R. & Rosser, A. (2021). Cell therapy in Huntington's disease: Taking stock of past studies to move the field forward. Stem Cells, 39(2), 144-155. doi:10.1002/stem.3300

Thiriez, C., Villafane, G., Grapin, F., Fenelon, G., Remy, P. & Cesaro, P. (2011). Can nicotine be used medicinally in Parkinson's disease? Expert review of clinical pharmacology, 4(4), 429-36. doi:10.1586/ecp.11.27

Jacquemot, C., Dupoux, E. & Bachoud-Levi, A. (2007). Breaking the mirror: Asymmetrical disconnection between the phonological input and output codes. Cognitive Neuropsychology, 24(1), 3-22. doi:10.1080/02643290600683342

Zuccato, C., Marullo, M., Vitali, B., Tarditi, A., Mariotti, C., Valenza, M., Lahiri, N., Wild, E., Sassone, J., Ciammola, A., Bachoud-Levi, A., Tabrizi, S., Di Donato, S. & Cattaneo, E. (2011). Brain-derived neurotrophic factor in patients with Huntington's disease. PloS one, 6(8), e22966. doi:10.1371/journal.pone.0022966

Van Der Gucht, A., Aoun Sebaiti, M., Guedj, E., Aouizerate, J., Yara, S., Gherardi, R., Evangelista, E., Chalaye, J., Cottereau, A., Verger, A., Bachoud-Levi, A., Abulizi, M., Itti, E. & Authier, F. (2017). Brain 18F-FDG PET Metabolic Abnormalities in Patients with Long-Lasting Macrophagic Myofascitis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 58(3), 492-498. doi:10.2967/jnumed.114.151878

Van Der Gucht, A., Cleret de Langavant, L., Bélissant, O., Rabu, C., Cottereau, A., Evangelista, E., Chalaye, J., Bonnot-Lours, S., Fenelon, G. & Itti, E. (2016). Brain (18)F-FDG, (18)F-Florbetaben PET/CT, (123)I-FP-CIT SPECT and Cardiac (123)I-MIBG Imaging for Diagnosis of a "Cerebral Type" of Lewy Body Disease. Nuclear medicine and molecular imaging, 50(3), 258-60. doi:10.1007/s13139-016-0394-0

Varani, K., Bachoud-Levi, A., Mariotti, C., Tarditi, A., Abbracchio, M., Gasperi, V., Borea, P., Dolbeau, G., Gellera, C., Solari, A., Rosser, A., Naji, J., Handley, O., Maccarrone, M., Peschanski, M., Didonato, S. & Cattaneo, E. (2007). Biological abnormalities of peripheral A2A receptors in a large representation of polyglutamine disorders and Huntington's disease stages. Neurobiology of Disease, 27(1), 36-43. doi:10.1016/j.nbd.2007.03.011

Vittori, A., Orth, M., Roos, R., Outeiro, T., Giorgini, F., Hollox, E. & Registry Investigators Of The European Huntington'S Disease, N. (2013). β-Defensin genomic copy number does not influence the age of onset in Huntington's Disease. Journal of Huntington's disease. doi:10.3233/jhd-130002

Vittori, A., Orth, M., Roos, R., Outeiro, T., Giorgini, F., Hollox, E., Bachoud-Levi, A. & Registry Investigators Of The European Huntington’s Disease, N. (2013). β-defensin genomic copy number does not influence the age of onset in huntington’s disease. Journal of Huntington's Disease, 2(1), 107-124. doi:10.3233/JHD-130047

Cleret de Langavant, L., Fenelon, G., Benisty, S., Boissé, M., Jacquemot, C. & Bachoud-Levi, A. (2013). Awareness of memory deficits in early stage Huntington's disease. PloS one, 8(4), e61676. doi:10.1371/journal.pone.0061676

Bayen , E., Cleret de Langavant, L., Gouriou, C. , Pradat-Diehl, P., Canouï-Poitrine, F., Yaffe , K. & Lawlor, B. (2020). Awareness of dementia risk and of brain-healthy lifestyles in medical students implementing new brain health classes in French schools. , 16(S10). doi:10.1002/alz.042091

Dalla Barba , G., Bartolomeo, P., Ergis, A., Boissé, M. & Bachoud-Levi, A. (1999). Awareness of anosognosia following head trauma. Neurocase, 5(1), 59-67. doi:10.1093/neucas/5.1.59

Louadfel, H. , Renard, L. , Levy, R., Faugeras, F., Kalsoum, E. , Nataf, E. , Neven, B. , Hosseini, H. & Bachoud-Levi, A. (2022). AVC ischémique sur dissection intracrânienne en lien avec un déficit en DOCK 8. Revue Neurologique, 178, S88. doi:10.1016/j.neurol.2022.02.325

Visser, E., Keuken, M., Douaud, G., Gaura, V., Bachoud-Levi, A., Remy, P., Forstmann, B. & Jenkinson, M. (2016). Automatic segmentation of the striatum and globus pallidus using MIST: Multimodal Image Segmentation Tool. NeuroImage, 125, 479-497. doi:10.1016/j.neuroimage.2015.10.013

Vandendriessche, C., Bastian, M., Peyre, H., Stordeur, C., Asquaviva, E., Bahadori, S., Delorme, R. & Sackur, J. (2017). Attentional Lapses in Attention-Deficit/Hyperactivity Disorder: Blank Rather Than Wandering Thoughts. Psychological Science, 28(10), 1375-1386. doi:10.1177/0956797617708234

Gaura, V., Lavisse, S., Payoux, P., Goldman, S., Verny, C., Krystkowiak, P., Damier, P., Supiot, F., Bachoud-Levi, A. & Remy, P. (2017). Association Between Motor Symptoms and Brain Metabolism in Early Huntington Disease. JAMA neurology, 74(9), 1088-1096. doi:10.1001/jamaneurol.2017.1200

Simonin, C., Duru, C., Salleron, J., Hincker, P., Charles, P., Delval, A., Youssov, K., Burnouf, S., Azulay, J., Verny, C., Scherer, C., Tranchant, C., Goizet, C., Debruxelles, S., Defebvre, L., Sablonnière, B., Romon-Rousseaux, M., Buée, L., Destée, A., Godefroy, O., Durr, A., Landwehrmeyer, B., Registry Study Of The European Huntington'S Disease, N., Bachoud-Levi, A., Richard, F., Blum, D., Krystkowiak, P. & Huntington French Speaking, N. (2013). Association between caffeine intake and age at onset in Huntington's disease. Neurobiology of disease, 58, 179-82. doi:10.1016/j.nbd.2013.05.013

Vaccarino, A., Sills, T., Anderson, K., Bachoud-Levi, A., Borowsky, B., Craufurd, D., Duff, K., Giuliano, J., Groves, M., Guttman, M., Kupchak, P., Ho, A., Paulsen, J., Pedersen, K., Van Duijn, E., Van Kammen, D. & Evans, K. (2011). Assessment of depression, anxiety and apathy in prodromal and early huntington disease. PLoS currents, 3, RRN1242. doi:10.1371/currents.RRN1242

Cleret de Langavant, L., Bayen , E. & Bachoud-Levi, A. (2020). Approximating dementia prevalence in population-based surveys of aging worldwide: An unsupervised machine learning approach. Alzheimer’s & Dementia: Translational Research & Clinical Interventions (TRCI), 6(1), e12074. doi:10.1002/trc2.12074

Levi Marpillat, N., Macquin-Mavier, I., Tropeano, A., Bachoud-Levi, A. & Maison, P. (2013). Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. Journal of hypertension, 31(6), 1073-82. doi:10.1097/HJH.0b013e3283603f53

Cleret de Langavant, L., Roze, E., Petit, A. , Tressières, B., Gharbi-Meliani, A., Chaumont, H., Pierre Michel, P., Bachoud-Levi, A., Remy, P., Edragas, R. & Lannuzel, A. (2022). Annonaceae Consumption Worsens Disease Severity and Cognitive Deficits in Degenerative Parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 37(12), 2355-2366. doi:10.1002/mds.29222

Lunven, M., Rode, G., Bourlon, C., Duret, C., Migliaccio, R., Chevrillon, E. , De Schotten, T. & Bartolomeo, P. (2019 ). Anatomical predictors of successful prism adaptation in chronic visual neglect. Cortex, S0010-9452(18), 30413-1. doi:10.1016/j.cortex.2018.12.004

Ferreira, J., Rodrigues, F. , Duarte, G. , Mestre, T., Bachoud-Levi, A. & (Et Al), . (2022). An MDS Evidence-Based Review on Treatments for Huntington's Disease. Mov Disord., 37(1), 25-35. doi:10.1002/mds.28855

Krystkowiak, P., Gaura, V., Labalette, M., Rialland, A., Remy, P., Peschanski, M. & Bachoud-Levi, A. (2007). Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease. PloS one, 2(1), e166. doi:10.1371/journal.pone.0000166

NGuyen, R. , Gravier, A. , Lesoil, C. , Bedet, A., Petit-Hoang, C. , Mahevas, M., Mekontso Dessap, A., Hodel, J. , Bachoud-Levi, A. & Cleret de Langavant, L. (2020). Acute Hippocampal Encephalopathy in Heavy Cannabis Users: About 2 Cases. The American Journal of Medicine(7), e360-e364. doi:10.1016/j.amjmed.2019.11.018